Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery
Portfolio Pulse from
A study published in Gland Surgery shows that breast cancer patients in Japan who underwent IceCure's ProSense® Cryoablation reported significantly higher satisfaction compared to those who had standard surgery. This supports a shift towards non-surgical treatments.
March 10, 2025 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IceCure Medical's ProSense® Cryoablation shows higher patient satisfaction in Japan, supporting a shift towards non-surgical breast cancer treatments.
The study highlights the effectiveness and patient satisfaction of IceCure's ProSense® Cryoablation, which could lead to increased adoption and demand for their product, positively impacting ICCM's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100